BitcoinSistemi
2025-06-17 20:58:07

Nasdaq-listed Tech Company Plans to Purchase $50 Million Worth of This Altcoin

Digital ophthalmic technology company Eyenovia announced that it has signed a $50 million private equity investment (PIPE) agreement with institutional investors. With this funding, the company plans to create a cryptocurrency reserve by purchasing HYPE, the native token of the Hyperliquid blockchain, and change the company's name to “Hyperion DeFi.” Its new ticker symbol will be “HYPD.” Eyenovia has also appointed Hyunsu Jung as Chief Investment Officer (CIO) and Board Member to lead its crypto treasury strategy. According to the company's press release, the $50 million investment will offer investors non-voting preferred stock, convertible into approximately 15.4 million shares at $3.25 per share, and approximately 30.8 million shares of stock at the same price (warrant). If the warrants are fully exercised, Eyenovia's total gross revenue could reach $150 million. Related News: Ripple Submits Flash New Document to Court in SEC Lawsuit “We are pleased to be among the companies that have adopted this strategy to evaluate the diversification, liquidity and long-term capital appreciation potential of cryptocurrencies. After examining all alternatives, we have determined that this step is in the best interest of our shareholders,” said CEO Michael Rowe. “I am honored to lead this pioneering crypto treasury strategy built around HYPE. We believe Hyperliquid is one of the fastest growing and most revenue-generating blockchains in the world,” said Jung, new Chief Investment Officer. With this agreement, Eyenovia aims to become one of the most active validators on the Hyperliquid network globally by purchasing over 1 million HYPE tokens. In addition, a staking program will be launched in collaboration with Anchorage Digital. *This is not investment advice. Continue Reading: Nasdaq-listed Tech Company Plans to Purchase $50 Million Worth of This Altcoin

Get Crypto Newsletter
Read the Disclaimer : All content provided herein our website, hyperlinked sites, associated applications, forums, blogs, social media accounts and other platforms (“Site”) is for your general information only, procured from third party sources. We make no warranties of any kind in relation to our content, including but not limited to accuracy and updatedness. No part of the content that we provide constitutes financial advice, legal advice or any other form of advice meant for your specific reliance for any purpose. Any use or reliance on our content is solely at your own risk and discretion. You should conduct your own research, review, analyse and verify our content before relying on them. Trading is a highly risky activity that can lead to major losses, please therefore consult your financial advisor before making any decision. No content on our Site is meant to be a solicitation or offer.